Brielle Benyon

May 25, 2022

For patients with advanced epithelial ovarian cancer, there were little — if any — differences in survival outcomes depending on when they received surgery.

May 25, 2022

Patients can still talk to their clinicians about enrolling in a sub-study of the FIRELIGHT-1 trial, analyzing tovorafenib plus pimasertib in progressive or refractory solid tumors with MAPK pathway aberrations.

May 24, 2022

Actor and cancer advocate Patrick Dempsey predicts that more focus will be put on complementary cancer care, such as nutrition and environmental factors, over the next several years.

May 24, 2022

Myelofibrosis may cause major impairments to a patient’s quality of life, which is why it is pertinent that patients work with their clinicians to address these side effects.

May 23, 2022

The FDA approved Vidaza for the treatment of pediatric patients with juvenile myelomonocytic leukemia.

May 23, 2022

Watch Dr. Srdan Vestovsek, from The University of Texas MD Anderson Cancer Center, discuss novel agents and clinical trials in myelofibrosis, during the CURE Educated Patient MPN Summit.

May 22, 2022

Watch Dr. Jamile Shammo, from Rush University Medical Center, discuss differentiating an essential thrombocythemia diagnosis, during the CURE Educated Patient MPN Summit.

May 20, 2022

NX-5948 may be able to pass through the blood-brain barrier in patients with B-cell malignancies, potentially making it a promising option for patients with disease in their central nervous system.

May 20, 2022

From PGA Tour golfer Justin Thomas’ new sun-protection line to soap opera actress Marnie Schulenburg’s breast cancer death and the first child to receive CAR-T cell therapy celebrating 10 years cancer-free, here’s what’s happening in the cancer space this week.

May 19, 2022

Despite Latino and Hispanic men being more likely to present with higher-risk prostate cancer, they are less likely to receive treatment for their disease compared to other ethnicities.

May 19, 2022

The Strata PATH trial will use a novel testing strategy to determine if certain patients with solid tumors can benefit from already-approved therapies.

May 18, 2022

Dying does not have the be scary, and there are resources available to help patients and their loved ones, explained an expert.

May 18, 2022

The hope, according to an expert, is that this trial will expand CAR-T cell therapy access to more patients with multiple myeloma.

May 17, 2022

Actor and cancer advocate Patrick Dempsey explains that when a loved one is diagnosed with cancer, it is important that family members make the moments they share together count.

May 17, 2022

The combination of Sarclisa, Kyprolis and dexamethasone improved progression-free survival in patients with pretreated, relapsed myeloma, and has potential to become a new standard of care, an expert said.

May 16, 2022

A nurse navigator explains how people in their profession create bonds with their patients and guide them through the cancer experience.

May 13, 2022

Discussing fertility risks and preservation options before starting cancer treatment can help patients feel empowered and have less regret in the future, explained a nurse practitioner.

May 11, 2022

When it comes to learning about their disease, patients with cancer can have different preferences, from wanting to discuss treatments with their providers or read handouts, while others may not want to know much at all.

May 09, 2022

Patients with cancer have so many resources available to them to learn about their disease as well as their treatment options, explained a research nurse from Dana-Farber Cancer Institute.

May 06, 2022

Treatment with androgen deprivation therapy in combination with Zytiga, docetaxel and prednisone improved radiographic progression-free survival and overall survival in patients with de novo metastatic castration-sensitive prostate cancer.

May 06, 2022

From “Leave It to Beaver” actor Tony Dow revealing his cancer diagnosis to a woman faking a cancer diagnosis to collect $100,000 in donations and a European soccer star finishing treatment, here’s what’s happening in the cancer space this week.

May 05, 2022

Mental wellbeing is more of a focus than ever before in cancer care, and while treatments continue to get better, there is still a long road ahead, according to Patrick Dempsey.

May 04, 2022

The first patient was dosed in a clinical trial evaluating the radiopharmaceutical agent, CycloSam, in patients with bone cancer or cancer that has metastasized to the bone.

May 04, 2022

Updated trial results showed that the use of Kisqali plus fulvestrant was associated with an approximate 33% decrease in risk of death for women with HR-positive, HER2-negative advanced breast cancer.

May 03, 2022

Results from a phase 3 trial showed that the combination of Nubeqa, docetaxel and androgen-deprivation therapy significantly decreased the risk of death for men with a certain type of prostate cancer.

May 02, 2022

The trial of CLR 131 (iopofosine) for relapsed/refractory Waldenstrom’s macroglobulinemia will continue, as the drug will be studied in an estimated 50 patients.

May 02, 2022

One of the most feared side effects from chemotherapy treatment is hair loss, but scalp cooling can help patients maintain their locks.

April 30, 2022

Watch Louise Gunter, from Texas Oncology, discuss IO/TKI-related side effects, during the CURE Educated Patient Kidney Cancer Summit.

April 29, 2022

From an osteosarcoma survivor modeling inclusivity in the fashion world to rock guitarist Paul “Bonehead” Arthurs being diagnosed with cancer, here’s what’s happening in the cancer space this week.

April 29, 2022

Watch Dr. Jeff Yorio, from Texas Oncology, discuss treatment with the combination of immunotherapy and tyrosine kinase inhibitors, during the CURE Educated Patient Kidney Cancer Summit.